Last updated on November 2017

Sarcopenia study


Brief description of study

Sarcopenia study

Detailed Study Description

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of 3-Month Subcutaneous REGN1033 Treatment in Patients with Sarcopenia

Clinical Study Identifier: TX3844

Contact Investigators or Research Sites near you

Start Over

Nicole Crockford

Spartanburg Medical Research
Spartanburg, SC USA